Thursday, 28 April 2011

Magnesorot




Magnesorot may be available in the countries listed below.


Ingredient matches for Magnesorot



Magnesium Orotate

Magnesium Orotate dihydrate (a derivative of Magnesium Orotate) is reported as an ingredient of Magnesorot in the following countries:


  • Germany

International Drug Name Search

Tuesday, 26 April 2011

Temisartan




Temisartan may be available in the countries listed below.


Ingredient matches for Temisartan



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Temisartan in the following countries:


  • Argentina

International Drug Name Search

Reukap




Reukap may be available in the countries listed below.


Ingredient matches for Reukap



Ephedrine

Ephedrine hydrochloride (a derivative of Ephedrine) is reported as an ingredient of Reukap in the following countries:


  • Bosnia & Herzegowina

International Drug Name Search

Saturday, 23 April 2011

Karbamazepin Nycomed




Karbamazepin Nycomed may be available in the countries listed below.


Ingredient matches for Karbamazepin Nycomed



Carbamazepine

Carbamazepine is reported as an ingredient of Karbamazepin Nycomed in the following countries:


  • Latvia

International Drug Name Search

Thursday, 21 April 2011

Captopril-50




Captopril-50 may be available in the countries listed below.


Ingredient matches for Captopril-50



Captopril

Captopril is reported as an ingredient of Captopril-50 in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, 16 April 2011

Razadyne ER


See also: Generic Razadyne


Razadyne ER is a brand name of galantamine, approved by the FDA in the following formulation(s):


RAZADYNE ER (galantamine hydrobromide - capsule, extended release; oral)



  • Manufacturer: JANSSEN PHARMS

    Approval date: April 1, 2005

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [RLD][AB]

Has a generic version of Razadyne ER been approved?


A generic version of Razadyne ER has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Razadyne ER and have been approved by the FDA:


galantamine hydrobromide capsule, extended release; oral



  • Manufacturer: BARR

    Approval date: September 15, 2008

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: IMPAX LABS

    Approval date: May 27, 2009

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: MYLAN

    Approval date: January 24, 2011

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: SUN PHARMA GLOBAL

    Approval date: February 2, 2011

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [AB]


  • Manufacturer: WATSON LABS

    Approval date: December 15, 2008

    Strength(s): EQ 16MG BASE [AB], EQ 24MG BASE [AB], EQ 8MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Razadyne ER. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Controlled release galantamine composition
    Patent 7,160,559
    Issued: January 9, 2007
    Inventor(s): McGee; John Paul & Gilis; Paul Marie Victor & De Weer; Marc Maurice Germain & de Condé; Valentin Florent Victor & de Bruijn; Herman Johannes Catherina & Van Dycke; Frederic Anne Rodolf
    Assignee(s): Janssen Pharmaceutica N.V.
    The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
    Patent expiration dates:

    • December 20, 2019
      ✓ 
      Drug product



See also...

  • Razadyne ER Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Razadyne ER Consumer Information (Cerner Multum)
  • Razadyne ER Advanced Consumer Information (Micromedex)
  • Galantamine Consumer Information (Wolters Kluwer)
  • Galantamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Galantamine Solution Consumer Information (Wolters Kluwer)
  • Galantamine Consumer Information (Cerner Multum)
  • Galantamine Advanced Consumer Information (Micromedex)
  • Galantamine Hydrobromide AHFS DI Monographs (ASHP)

Sunday, 10 April 2011

Amlodipina Alter




Amlodipina Alter may be available in the countries listed below.


Ingredient matches for Amlodipina Alter



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipina Alter in the following countries:


  • Italy

  • Portugal

International Drug Name Search

Friday, 8 April 2011

Roxin




Roxin may be available in the countries listed below.


Ingredient matches for Roxin



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Roxin in the following countries:


  • Sri Lanka

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Roxin in the following countries:


  • Turkey

Levothyroxine

Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Roxin in the following countries:


  • India

Norfloxacin

Norfloxacin is reported as an ingredient of Roxin in the following countries:


  • Australia

International Drug Name Search

Monday, 4 April 2011

Alprazolam Ur




Alprazolam Ur may be available in the countries listed below.


Ingredient matches for Alprazolam Ur



Alprazolam

Alprazolam is reported as an ingredient of Alprazolam Ur in the following countries:


  • Spain

International Drug Name Search

Saturday, 2 April 2011

Parkinane LP




Parkinane LP may be available in the countries listed below.


Ingredient matches for Parkinane LP



Trihexyphenidyl

Trihexyphenidyl hydrochloride (a derivative of Trihexyphenidyl) is reported as an ingredient of Parkinane LP in the following countries:


  • France

International Drug Name Search

Lisozima Spa




Lisozima Spa may be available in the countries listed below.


Ingredient matches for Lisozima Spa



Lysozyme

Lysozyme hydrochloride (a derivative of Lysozyme) is reported as an ingredient of Lisozima Spa in the following countries:


  • Italy

International Drug Name Search

Friday, 1 April 2011

Biovermes




Biovermes may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biovermes



Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Biovermes in the following countries:


  • Portugal

International Drug Name Search

Medipekt




Medipekt may be available in the countries listed below.


Ingredient matches for Medipekt



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Medipekt in the following countries:


  • Finland

International Drug Name Search